97 related articles for article (PubMed ID: 26515411)
1. Predictive model for survival in patients having repeat radiation treatment for painful bone metastases.
Chow E; Ding K; Parulekar WR; Wong RK; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JS; Nabid A; Leer JW; Vonk E; Babington S; Demas WF; Wilson CF; Brundage M; Zhu L; Meyer RM
Radiother Oncol; 2016 Mar; 118(3):547-51. PubMed ID: 26515411
[TBL] [Abstract][Full Text] [Related]
2. An easy tool to predict survival in patients receiving radiation therapy for painful bone metastases.
Westhoff PG; de Graeff A; Monninkhof EM; Bollen L; Dijkstra SP; van der Steen-Banasik EM; van Vulpen M; Leer JW; Marijnen CA; van der Linden YM;
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):739-47. PubMed ID: 25260489
[TBL] [Abstract][Full Text] [Related]
3. Predicting the survival of patients with bone metastases treated with radiation therapy: a validation study of the Katagiri scoring system.
Kubota H; Soejima T; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Tsujino K; Fujita I; Fujimoto T; Morishita M; Ikegaki J; Matsumoto K; Sasaki R
Radiat Oncol; 2019 Jan; 14(1):13. PubMed ID: 30658673
[TBL] [Abstract][Full Text] [Related]
4. Consideration of patient and disease characteristics in selecting radiation regimens for treatment of bone metastases.
Liu Y; von Eyben R; Kidd EA
Pract Radiat Oncol; 2017; 7(6):403-410. PubMed ID: 28751228
[TBL] [Abstract][Full Text] [Related]
5. Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial.
Chow E; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JS; Brundage MD; Nabid A; Tissing-Tan CJ; Oei B; Babington S; Demas WF; Wilson CF; Meyer RM; Chen BE; Wong RK
Lancet Oncol; 2014 Feb; 15(2):164-71. PubMed ID: 24369114
[TBL] [Abstract][Full Text] [Related]
6. [Radiosensitivity of bone metastases from tumors in different primary sites].
Khmelevsky EV; Bychkova NM
Vopr Onkol; 2015; 61(1):77-84. PubMed ID: 26016150
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05).
Roos DE; Turner SL; O'Brien PC; Smith JG; Spry NA; Burmeister BH; Hoskin PJ; Ball DL;
Radiother Oncol; 2005 Apr; 75(1):54-63. PubMed ID: 15878101
[TBL] [Abstract][Full Text] [Related]
8. Validation of a predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic.
Chow E; Abdolell M; Panzarella T; Harris K; Bezjak A; Warde P; Tannock I
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):280-7. PubMed ID: 18676092
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy for neuropathic pain due to bone metastases.
Roos DE
Ann Palliat Med; 2015 Oct; 4(4):220-4. PubMed ID: 26541402
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and a new scoring system for survival of patients irradiated for bone metastases.
Rades D; Haus R; Schild SE; Janssen S
BMC Cancer; 2019 Nov; 19(1):1156. PubMed ID: 31779595
[TBL] [Abstract][Full Text] [Related]
11. Quality of Life in Relation to Pain Response to Radiation Therapy for Painful Bone Metastases.
Westhoff PG; de Graeff A; Monninkhof EM; Pomp J; van Vulpen M; Leer JW; Marijnen CA; van der Linden YM;
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):694-701. PubMed ID: 26281825
[TBL] [Abstract][Full Text] [Related]
12. Re-irradiation for painful bone metastases - a systematic review.
Wong E; Hoskin P; Bedard G; Poon M; Zeng L; Lam H; Vulpe H; Tsao M; Pulenzas N; Chow E
Radiother Oncol; 2014 Jan; 110(1):61-70. PubMed ID: 24094630
[TBL] [Abstract][Full Text] [Related]
13. Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: results on survival in the Dutch Bone Metastasis Study.
van der Linden YM; Steenland E; van Houwelingen HC; Post WJ; Oei B; Marijnen CA; Leer JW;
Radiother Oncol; 2006 Mar; 78(3):245-53. PubMed ID: 16545474
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.
Hartsell WF; Scott CB; Bruner DW; Scarantino CW; Ivker RA; Roach M; Suh JH; Demas WF; Movsas B; Petersen IA; Konski AA; Cleeland CS; Janjan NA; DeSilvio M
J Natl Cancer Inst; 2005 Jun; 97(11):798-804. PubMed ID: 15928300
[TBL] [Abstract][Full Text] [Related]
15. Palliative radiotherapy for painful bone metastases from solid tumors delivered with static ports of tomotherapy (TomoDirect): feasibility and clinical results.
Franco P; Migliaccio F; Angelini V; Cante D; Sciacero P; Peruzzo Cornetto A; Casanova Borca V; Zeverino M; Torielli P; Arrichiello C; Girelli G; La Porta MR; Tofani S; Numico G; Ricardi U
Cancer Invest; 2014 Nov; 32(9):458-63. PubMed ID: 25259607
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction.
Foro Arnalot P; Fontanals AV; Galcerán JC; Lynd F; Latiesas XS; de Dios NR; Castillejo AR; Bassols ML; Galán JL; Conejo IM; López MA
Radiother Oncol; 2008 Nov; 89(2):150-5. PubMed ID: 18556080
[TBL] [Abstract][Full Text] [Related]
17. Predictive model for survival in patients with advanced cancer.
Chow E; Abdolell M; Panzarella T; Harris K; Bezjak A; Warde P; Tannock I
J Clin Oncol; 2008 Dec; 26(36):5863-9. PubMed ID: 19018082
[TBL] [Abstract][Full Text] [Related]
18. Continuing evidence for poorer treatment outcomes for single male patients: retreatment data from RTOG 97-14.
Konski A; Desilvio M; Hartsell W; Watkins-Bruner D; Coyne J; Scarantino C; Janjan N
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):229-33. PubMed ID: 16814950
[TBL] [Abstract][Full Text] [Related]
19. International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice?
Fairchild A; Barnes E; Ghosh S; Ben-Josef E; Roos D; Hartsell W; Holt T; Wu J; Janjan N; Chow E
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1501-10. PubMed ID: 19464820
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
Gravis G; Boher JM; Fizazi K; Joly F; Priou F; Marino P; Latorzeff I; Delva R; Krakowski I; Laguerre B; Walz J; Rolland F; Théodore C; Deplanque G; Ferrero JM; Pouessel D; Mourey L; Beuzeboc P; Zanetta S; Habibian M; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Labourey JL; Machiels JP; El Kouri C; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Soulie M; Oudard S
Eur Urol; 2015 Aug; 68(2):196-204. PubMed ID: 25277272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
